RARE - Ultragenyx Pharmaceutical Inc.
IEX Last Trade
56.78
-0.180 -0.317%
Share volume: 754,442
Last Updated: Fri 30 Aug 2024 09:59:54 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$56.96
-0.18
-0.32%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-17 | 2023-05-05 | 2023-08-04 | 2023-11-03 | 2024-02-21 | 2024-05-03 | 2024-08-02 | |
| Total revenue | 90.703 M | 103.348 M | 100.496 M | 108.309 M | 98.052 M | 127.392 M | 108.833 M | 147.026 M | |
| Cost of revenue | 8.631 M | 5.319 M | 12.257 M | 9.914 M | 10.987 M | 12.051 M | 17.533 M | 21.280 M | |
| Gross profit | 82.072 M | 98.029 M | 88.239 M | 98.395 M | 87.065 M | 115.341 M | 91.300 M | 125.746 M | |
| 19.44% | -9.99% | 11.51% | -11.51% | 32.48% | -20.84% | 37.73% | |||
| Operating expenses | 307.138 M | 243.657 M | 242.344 M | 246.352 M | 232.162 M | 237.390 M | 256.647 M | 242.107 M | |
| Selling general and admin | 69.841 M | 72.849 M | 76.646 M | 81.403 M | 74.917 M | 76.833 M | 78.160 M | 80.604 M | |
| Research and development | 237.297 M | 170.808 M | 165.698 M | 164.949 M | 157.245 M | 160.557 M | 178.487 M | 161.503 M | |
| Total expenses | 315.769 M | 248.976 M | 254.601 M | 256.266 M | 243.149 M | 249.441 M | 274.180 M | 263.387 M | |
| -21.15% | 2.26% | 0.65% | -5.12% | 2.59% | 9.92% | -3.94% | |||
| Operating income | -225.066 M | -145.628 M | -154.105 M | -147.957 M | -145.097 M | -122.049 M | -165.347 M | -116.361 M | |
| Ebit | -225.066 M | -145.628 M | -154.105 M | -147.957 M | -145.097 M | -122.049 M | -165.347 M | -116.361 M | |
| Pretax income | -238.819 M | -153.284 M | -163.477 M | -159.096 M | -158.999 M | -126.892 M | -170.229 M | -130.740 M | |
| -35.82% | 6.65% | -2.68% | -0.06% | -20.19% | 34.15% | -23.20% | |||
| Income tax | 6.287 M | -1.451 M | 495.000 K | 732.000 K | 650.000 K | -3.702 M | 455.000 K | 858.000 K | |
| Net income basic | -245.106 M | -151.833 M | -163.972 M | -159.828 M | -159.649 M | -123.190 M | -170.684 M | -131.598 M | |
| 38.05% | -7.99% | 2.53% | 0.11% | 22.84% | -38.55% | 22.90% | |||
| Net income | -245.106 M | -151.833 M | -163.972 M | -159.828 M | -159.649 M | -123.190 M | -170.684 M | -131.598 M | |
| 38.05% | -7.99% | 2.53% | 0.11% | 22.84% | -38.55% | 22.90% |